Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
Market Analysis and Insights: Global Biosynthesis of Cannabinoids Market
The global Biosynthesis of Cannabinoids market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Biosynthesis of Cannabinoids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Biosynthesis of Cannabinoids include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % revenue of Biosynthesis of Cannabinoids went into Food Industry filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Biosynthesis of Cannabinoids market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Biosynthesis of Cannabinoids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biosynthesis of Cannabinoids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biosynthesis of Cannabinoids revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Biosynthesis of Cannabinoids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biosynthesis of Cannabinoids revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others
Segment by Application
Food Industry
Medical Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Biosynthesis of Cannabinoids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosynthesis of Cannabinoids companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biosynthesis of Cannabinoids revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 THC
1.2.3 CBD
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosynthesis of Cannabinoids Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Food Industry
1.3.3 Medical Industry
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosynthesis of Cannabinoids Market Perspective (2019-2030)
2.2 Global Biosynthesis of Cannabinoids Growth Trends by Region
2.2.1 Biosynthesis of Cannabinoids Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biosynthesis of Cannabinoids Historic Market Size by Region (2019-2024)
2.2.3 Biosynthesis of Cannabinoids Forecasted Market Size by Region (2025-2030)
2.3 Biosynthesis of Cannabinoids Market Dynamics
2.3.1 Biosynthesis of Cannabinoids Industry Trends
2.3.2 Biosynthesis of Cannabinoids Market Drivers
2.3.3 Biosynthesis of Cannabinoids Market Challenges
2.3.4 Biosynthesis of Cannabinoids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Biosynthesis of Cannabinoids by Players
3.1.1 Global Biosynthesis of Cannabinoids Revenue by Players (2019-2024)
3.1.2 Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2019-2024)
3.2 Global Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Biosynthesis of Cannabinoids, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Biosynthesis of Cannabinoids Market Concentration Ratio
3.4.1 Global Biosynthesis of Cannabinoids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosynthesis of Cannabinoids Revenue in 2023
3.5 Global Key Players of Biosynthesis of Cannabinoids Head office and Area Served
3.6 Global Key Players of Biosynthesis of Cannabinoids, Product and Application
3.7 Global Key Players of Biosynthesis of Cannabinoids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosynthesis of Cannabinoids Breakdown Data by Type
4.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2019-2024)
4.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2025-2030)
5 Biosynthesis of Cannabinoids Breakdown Data by Application
5.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2019-2024)
5.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biosynthesis of Cannabinoids Market Size (2019-2030)
6.2 North America Biosynthesis of Cannabinoids Market Size by Type
6.2.1 North America Biosynthesis of Cannabinoids Market Size by Type (2019-2024)
6.2.2 North America Biosynthesis of Cannabinoids Market Size by Type (2025-2030)
6.2.3 North America Biosynthesis of Cannabinoids Market Share by Type (2019-2030)
6.3 North America Biosynthesis of Cannabinoids Market Size by Application
6.3.1 North America Biosynthesis of Cannabinoids Market Size by Application (2019-2024)
6.3.2 North America Biosynthesis of Cannabinoids Market Size by Application (2025-2030)
6.3.3 North America Biosynthesis of Cannabinoids Market Share by Application (2019-2030)
6.4 North America Biosynthesis of Cannabinoids Market Size by Country
6.4.1 North America Biosynthesis of Cannabinoids Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
6.4.3 North America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Biosynthesis of Cannabinoids Market Size (2019-2030)
7.2 Europe Biosynthesis of Cannabinoids Market Size by Type
7.2.1 Europe Biosynthesis of Cannabinoids Market Size by Type (2019-2024)
7.2.2 Europe Biosynthesis of Cannabinoids Market Size by Type (2025-2030)
7.2.3 Europe Biosynthesis of Cannabinoids Market Share by Type (2019-2030)
7.3 Europe Biosynthesis of Cannabinoids Market Size by Application
7.3.1 Europe Biosynthesis of Cannabinoids Market Size by Application (2019-2024)
7.3.2 Europe Biosynthesis of Cannabinoids Market Size by Application (2025-2030)
7.3.3 Europe Biosynthesis of Cannabinoids Market Share by Application (2019-2030)
7.4 Europe Biosynthesis of Cannabinoids Market Size by Country
7.4.1 Europe Biosynthesis of Cannabinoids Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
7.4.3 Europe Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Biosynthesis of Cannabinoids Market Size (2019-2030)
8.2 China Biosynthesis of Cannabinoids Market Size by Type
8.2.1 China Biosynthesis of Cannabinoids Market Size by Type (2019-2024)
8.2.2 China Biosynthesis of Cannabinoids Market Size by Type (2025-2030)
8.2.3 China Biosynthesis of Cannabinoids Market Share by Type (2019-2030)
8.3 China Biosynthesis of Cannabinoids Market Size by Application
8.3.1 China Biosynthesis of Cannabinoids Market Size by Application (2019-2024)
8.3.2 China Biosynthesis of Cannabinoids Market Size by Application (2025-2030)
8.3.3 China Biosynthesis of Cannabinoids Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Biosynthesis of Cannabinoids Market Size (2019-2030)
9.2 Asia Biosynthesis of Cannabinoids Market Size by Type
9.2.1 Asia Biosynthesis of Cannabinoids Market Size by Type (2019-2024)
9.2.2 Asia Biosynthesis of Cannabinoids Market Size by Type (2025-2030)
9.2.3 Asia Biosynthesis of Cannabinoids Market Share by Type (2019-2030)
9.3 Asia Biosynthesis of Cannabinoids Market Size by Application
9.3.1 Asia Biosynthesis of Cannabinoids Market Size by Application (2019-2024)
9.3.2 Asia Biosynthesis of Cannabinoids Market Size by Application (2025-2030)
9.3.3 Asia Biosynthesis of Cannabinoids Market Share by Application (2019-2030)
9.4 Asia Biosynthesis of Cannabinoids Market Size by Region
9.4.1 Asia Biosynthesis of Cannabinoids Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Biosynthesis of Cannabinoids Market Size by Region (2019-2024)
9.4.3 Asia Biosynthesis of Cannabinoids Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type
10.2.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application
10.3.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country
10.4.1 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Biosynthesis of Cannabinoids Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Anandia Laboratories
11.1.1 Anandia Laboratories Company Details
11.1.2 Anandia Laboratories Business Overview
11.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Introduction
11.1.4 Anandia Laboratories Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.1.5 Anandia Laboratories Recent Developments
11.2 Gingko Bioworks
11.2.1 Gingko Bioworks Company Details
11.2.2 Gingko Bioworks Business Overview
11.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Introduction
11.2.4 Gingko Bioworks Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.2.5 Gingko Bioworks Recent Developments
11.3 Hyasynth Bio
11.3.1 Hyasynth Bio Company Details
11.3.2 Hyasynth Bio Business Overview
11.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Introduction
11.3.4 Hyasynth Bio Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.3.5 Hyasynth Bio Recent Developments
11.4 InMed Pharmaceuticals
11.4.1 InMed Pharmaceuticals Company Details
11.4.2 InMed Pharmaceuticals Business Overview
11.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.4.4 InMed Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.4.5 InMed Pharmaceuticals Recent Developments
11.5 Librede
11.5.1 Librede Company Details
11.5.2 Librede Business Overview
11.5.3 Librede Biosynthesis of Cannabinoids Introduction
11.5.4 Librede Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.5.5 Librede Recent Developments
11.6 Renew Biopharma
11.6.1 Renew Biopharma Company Details
11.6.2 Renew Biopharma Business Overview
11.6.3 Renew Biopharma Biosynthesis of Cannabinoids Introduction
11.6.4 Renew Biopharma Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.6.5 Renew Biopharma Recent Developments
11.7 Cronos Group
11.7.1 Cronos Group Company Details
11.7.2 Cronos Group Business Overview
11.7.3 Cronos Group Biosynthesis of Cannabinoids Introduction
11.7.4 Cronos Group Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.7.5 Cronos Group Recent Developments
11.8 Organigram
11.8.1 Organigram Company Details
11.8.2 Organigram Business Overview
11.8.3 Organigram Biosynthesis of Cannabinoids Introduction
11.8.4 Organigram Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.8.5 Organigram Recent Developments
11.9 Teewinot Life Sciences
11.9.1 Teewinot Life Sciences Company Details
11.9.2 Teewinot Life Sciences Business Overview
11.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Introduction
11.9.4 Teewinot Life Sciences Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.9.5 Teewinot Life Sciences Recent Developments
11.10 ICC International Cannabis Corp.
11.10.1 ICC International Cannabis Corp. Company Details
11.10.2 ICC International Cannabis Corp. Business Overview
11.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Introduction
11.10.4 ICC International Cannabis Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.10.5 ICC International Cannabis Corp. Recent Developments
11.11 Biotii Technologies Corp.
11.11.1 Biotii Technologies Corp. Company Details
11.11.2 Biotii Technologies Corp. Business Overview
11.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Introduction
11.11.4 Biotii Technologies Corp. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.11.5 Biotii Technologies Corp. Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Introduction
11.12.4 Bristol-Myers Squibb Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Biogen Inc.
11.13.1 Biogen Inc. Company Details
11.13.2 Biogen Inc. Business Overview
11.13.3 Biogen Inc. Biosynthesis of Cannabinoids Introduction
11.13.4 Biogen Inc. Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.13.5 Biogen Inc. Recent Developments
11.14 GW Pharmaceuticals
11.14.1 GW Pharmaceuticals Company Details
11.14.2 GW Pharmaceuticals Business Overview
11.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Introduction
11.14.4 GW Pharmaceuticals Revenue in Biosynthesis of Cannabinoids Business (2019-2024)
11.14.5 GW Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
听
听
*If Applicable.
